Deutsche International Growth S Fund (SCOBX - Free Report) seeks long-term appreciation of capital. SCOBX normally invests in the securities of non-U.S. issuers across the globe, with any market capitalization. SCOBX invests in preferred stocks, convertible securities and warrants. SCOBX also invests about one-fifth of its assets in securities of domestic issuers.
This Global - Equity producthas a history of positive total returns for over 10 years. Specifically, the fund’s returns over the 3, 5 year benchmarks; 3 year 6.2% and 5 year almost 9.9%. To see how this fund performed compared in its category, and other #1 and #2 Ranked Mutual Funds, please click here.
The Deutsche International Growth S Fund, as of the last filing, allocates their fund in top two major groups; Foreign Stock and Large Growth. Further, as of the last filing, Alphabet Inc A, Brookfield Asset Management Inc Class A and Celgene Corp were the top holdings for SCOBX.
This Zacks Rank #2 (Buy) was incepted in July 1986 and is managed by Deutsche AWM. SCOBX carries an expense ratio of 0.93% and requires a minimal initial investment of $2,500.
Want key mutual fund info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing mutual funds, each week. Get it free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Deutsche International Growth S Fund (SCOBX - Free Report) seeks long-term appreciation of capital. SCOBX normally invests in the securities of non-U.S. issuers across the globe, with any market capitalization. SCOBX invests in preferred stocks, convertible securities and warrants. SCOBX also invests about one-fifth of its assets in securities of domestic issuers.
This Global - Equity producthas a history of positive total returns for over 10 years. Specifically, the fund’s returns over the 3, 5 year benchmarks; 3 year 6.2% and 5 year almost 9.9%. To see how this fund performed compared in its category, and other #1 and #2 Ranked Mutual Funds, please click here.
The Deutsche International Growth S Fund, as of the last filing, allocates their fund in top two major groups; Foreign Stock and Large Growth. Further, as of the last filing, Alphabet Inc A, Brookfield Asset Management Inc Class A and Celgene Corp were the top holdings for SCOBX.
This Zacks Rank #2 (Buy) was incepted in July 1986 and is managed by Deutsche AWM. SCOBX carries an expense ratio of 0.93% and requires a minimal initial investment of $2,500.
Want key mutual fund info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing mutual funds, each week. Get it free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on SCOBX - FREE